While Sylvamo's earnings and sales for Q1 2024 surpassed analyst expectations, the significant year-over-year declines in both earnings (57.37%) and sales (5.63%) could temper investor enthusiasm. The beat on estimates may provide short-term positive sentiment, but the substantial decrease compared to the previous year's performance could raise concerns about the company's growth trajectory and profitability, leading to a neutral short-term impact on the stock price.